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Abstract
Introduction: Kaposi's sarcomas have been associated with different conditions of immunosuppression and are also 
known to be a typical complication of solid organ transplantations.
Case presentation: We report the case of a 65-year-old Turkish man with a history of heart transplantation 10 months 
ago who presented for clarification of his dyspnea. The patient had a known history of chronic obstructive pulmonary 
disease and a smoking history of 40 pack years. Radiologically, three progressively growing intra-pulmonary nodules 
were detected. The histology was diagnostic for a Kaposi's sarcoma. Visceral and especially primary intra-pulmonary 
Kaposi's sarcomas are very rare and have been described to have a rather unfavorable prognosis.
Conclusions: Even with a history suggestive for conventional lung cancer, Kaposi's sarcomas should be considered in 
patients after transplantation of solid organs. It should be noted that in a minority of cases this tumor exists in the 
absence of the typical cutaneous lesions.
Introduction
Kaposi's sarcomas are infrequent malignant tumors in the
USA derived from vasoformative mesenchyme with a
higher regional prevalence (endemic form) in the Medi-
terranean basin, the Middle East and Eastern Europe and
in immunocompromised patients [1]. The latter encom-
passes mainly patients with acquired immunodeficiency
syndrome (AIDS) and to a lesser extent individuals with
other causes of compromised immunity, for example
after solid organ transplantation (so called iatrogenic
forms). It was estimated that the frequency of Kaposi's
sarcoma in AIDS patients is still several hundred times
higher than that in immunocompromised patients of
other causes [1]. Classic (cutaneous) Kaposi's sarcoma
typically manifests as bluish-red, well demarcated, pain-
less dermal maculae, plaques or nodules in the distal
lower extremities, which can become pedunculated and
may ulcerate. Advanced lesions might display a brown
color and hyper-keratotic surfaces. In addition to
mucosal involvements visceral tumors (lymph nodes, gas-
trointestinal tract, lung, spleen) have been described for
advanced cases and rarely as primary manifestations [1].
Most Kaposi's sarcomas were found in individuals older
than 50 years with a clear male predominance. The
course of these tumors is generally prolonged, although
short courses have been described [1].
In the 1990 s the connection between the human her-
pes virus 8 (HHV8) and Kaposi's sarcomas was estab-
lished. Virtually all Kaposi's sarcomas are thought to
harbor this virus which can be detected by immunohis-
tochemical and molecular-pathological techniques [1].
In this case report we describe the rare case of a pri-
mary intra-pulmonary Kaposi's sarcoma in a human
immunodeficiency virus (HIV)-negative 65-year-old man
with a history of heart transplantation 10 months previ-
ously.
Case presentation
A 65-year-old Turkish man presented to the hospital for
clarification of dyspnea. Computed tomography (CT)
showed a small tumor in the lower lobe of the left lung.
Subsequent bronchial lavage was non-contributive con-
cerning possible viral, bacterial (including mycobacteria)
and fungal causes or malignancy. It was decided to per-
form a follow-up CT in three months.
Our patient had a medical history of heart transplanta-
tion 10 months previously due to biventricular heart
insufficiency, chronic atrial fibrillation and multi-vessel
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Page 2 of 4coronary heart disease. Additionally, he had known
chronic obstructive pulmonary disease (COPD; smoking
history of 40 pack years), hyper-cholesterinemia, substi-
tuted hypothyroidism, articular gout, normocytic normo-
chromic anemia, steroid induced myopathia and obesity,
hypertrichosis (following therapy with cyclosporine) and
a recently polymerase chain reaction (PCR)-confirmed
cytomegaly virus infection. Follow-up CT after three and
four months displayed three progressively growing
tumors in the upper and lower lobe of the left lung (up to
1.6 cm) and in the lower right lobe (Figure 1A, B). Physi-
cal examination revealed no relevant findings. There
were no palpable lymph nodes, no signs of tumors on the
extremities and the skin.
Since the above described lesions were not thoraco-
scopically detectable, an open thoracotomy was per-
formed. The tumors in the left upper and lower lobe were
surgically removed by wedge resection. One of the
tumors was sent for intra-operative frozen section. Mac-
roscopically, the tumor was red-brown and well demar-
cated from the surrounding parenchyma. Histologically,
the frozen section revealed an intra-pulmonary spindle-
cell tumor. Intra-operatively the dignity of the tumor
could not be definitely determined. On paraffin sections,
the hematoxylin and eosin staining in all obtained speci-
mens displayed rather monomorphic spindle-cell tumors
(Figure 2A) with slit-like vascular clefts, entrapped eryth-
rocytes and evidence of older hemorrhages. Tumor cells
were positive for vascular molecular markers (CD 31, Fig-
ure 2B), moderately proliferating, and showed a fine
granular nuclear positivity for HHV8 (LNA-1, Figure 2C).
These findings were diagnostic for Kaposi's sarcoma.
In the post-operative course our patient was transferred
to the intensive care unit for two days for short-term
intubation owing to pulmonary edema and reduced
diuresis. He recovered well and was transferred back to
the normal ward. Heart and lung function were normal.
Our patient was able to leave hospital on the tenth post-
operative day. Immunosuppressive therapy was changed
from cyclosporine to everolimus and a follow-up CT in
three months was arranged. In the meantime the immu-
nosuppressive therapy might be further adapted to a pos-
sible chemotherapy.
Discussion
Iatrogenic (post-transplantation) Kaposi's sarcomas are
most often detected in patients with a previous history of
Figure 1 Lung imaging. Computed tomography displaying the pro-
gressively growing tumors (arrows) in the left (A) and right (B) lung.
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Figure 2 Histological images. Hematoxylin and eosin staining (A) of 
the intra-pulmonary tumor with the distinctive slit-like vascular clefts 
(arrows). The tumor cells are positive for the vascular marker CD31 (B) 
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Page 3 of 4kidney transplantation, which reflects the higher fre-
quency of these transplantations. The rate of post-trans-
plantation Kaposi's sarcoma was estimated at about 0.5%
(range 0.06% to 4.1%). The majority of cases, including
the one described, have been of patients originating from
the Mediterranean, the Middle East area or African
regions, known for the endemic form of this tumor entity.
For some of the patients with iatrogenic Kaposi's sarcoma
the hypothesis is that the tumor cells originated from
infected progenitor cells received from the donated
organ.
Larger studies have already described Kaposi's sarco-
mas following heart transplantation [2,3]. In most of
these cases, the tumors were localized in the skin but
some tumors also demonstrated visceral involvement
(lymph nodes, uterine cervix, gum, tonsils, lung and
heart). Likewise, very recently Sharif-Kashani et al.
reported a case of cutaneous and diffuse pulmonary
involvement six months after heart transplantation [4].
Indeed the visceral involvement is supposed to be more
frequent following heart or liver transplantations in com-
parison to renal transplantations [2]. The overall fre-
quency of purely visceral Kaposi's sarcomas is thought to
be around 10% after solid organ transplantation [2]. How-
ever, case reports describing a solitary involvement of the
lung following heart transplantation are extremely rare
[5]. Table 1 depicts published cases of purely visceral
Kaposi's sarcoma following heart transplantations. We
also detected six cases of lung involving, non-cutaneous
Kaposi's sarcoma after lung transplantation in the litera-
ture.
Wasywich et al. reported the case of a 42-year-old man
who had developed multiple intra-pulmonary Kaposi's
sarcomas 28 days after heart transplantation [5]. As in
our case no other tumor nodules were detected. For the
patient in Wasywich's case a remission for about two
years was achieved by switching from cyclosporine and
azathioprine to sirolimus. However, eventually lymph
node metastasis occurred [5].
Cases of primary pulmonary Kaposi's sarcoma were
mostly associated with AIDS, but have also been
described as rare complications of other solid organ
transplantations [6]. Like involvement of other visceral
organs, most cases represent primary cutaneous Kaposi's
sarcomas with additional visceral components [2,4]. Only
one case of an immunocompetent young man with pul-
monary Kaposi's sarcoma has been described so far [7].
Typical but unspecific radiological features of Kaposi's
sarcoma in such patients were nodular or reticular opaci-
ties, pleural effusions and hilar/mediastinal lymphade-
nopathy.
Interestingly, in contrast to our case, most reports in
the literature describe primary and secondary pulmonary
Kaposi's sarcoma with multiple nodular manifestations.
Although this case underlines that, even in the absence of
skin manifestations, one should consider Kaposi's sar-
coma as a possible cause of an intra-pulmonary tumor,
common lung cancers (especially adenocarcinomas) are
also important and frequent differential diagnoses in
heart transplant patients.
For post-transplantation patients with Kaposi's sar-
coma the five-year survival rate was observed at about
68% and these patients had a rather high rate of visceral
involvement (47%) [8]. Since many patients - including
our own - received cyclosporine, it is thought that there
might be causative connection. Several studies suggest
that the omission of cyclosporine might lead to tumor
remission [5]. Complete remission of Kaposi's sarcomas
was described using a combination of immunomodula-
tion (reduced/changed immunosuppression), irradiation
and surgery [8]. However, for patients with visceral
involvement, as well as for those with previous heart
transplantation, the prognosis was worse than for other
post-transplantation Kaposi's sarcoma cases [8]. Woodle
et al. therefore recommended a more aggressive combi-
nation therapy in such cases [8].
Conclusions
In conclusion we report a rare case of Kaposi's sarcoma
following heart transplantation with primary intra-pul-
monary manifestation without skin lesions. Even with a
history suggestive for lung cancer, Kaposi's sarcoma
should be considered as a differential diagnosis in
patients after transplantation of solid organs. The prog-
Table 1: Purely visceral Kaposi's sarcomas after heart transplantation
Author; year of publication No. of patients Localization
Bhoopchand A; 1986 [9] 1 lymph nodes
Lopez-Rubio F; 1994 [10] 1 bone, lungs, gastrointestinal, lymph nodes and liver
Fonesca R; 1998 [11] 1 gastrointestinal and lung
Jones D; 1998 [12] 1 lymph nodes
Collart F; 2004 [13] 1 gums, tonsils, lymph nodes
Wasywich CA; 2006 [5] 1 lung
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be rather serious and requires intensive follow-up and
consideration of different therapeutic measurements.
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